問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Kaoshiung Chang Gung Memorial Hospital of the C.G.M.F.
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2025-04-01 - 2027-12-31
Condition/Disease
OS (defined as the time elapsed from random assignment to death for any reason)
Test Drug
LIBTAYO THIO
Participate Sites10Sites
Recruiting10Sites
2025-04-01 - 2030-06-18
Advanced hepatocellular carcinoma
Atezolizumab Bevacizumab Rilvegostomig (AZD2936) Tremelimumab
Participate Sites8Sites
Recruiting8Sites
2020-09-01 - 2026-12-31
Participate Sites4Sites
Recruiting4Sites
2021-02-01 - 2027-12-31
Participate Sites6Sites
Recruiting6Sites
2023-08-01 - 2032-06-30
Participate Sites7Sites
Recruiting7Sites
2021-09-01 - 2027-12-31
2021-09-01 - 2028-12-31
Participate Sites3Sites
Recruiting3Sites
2018-05-01 - 2026-12-31
2018-12-01 - 2027-12-31
Division of Hematology & Oncology
2025-09-15 - 2030-12-31
全部
